Overview

Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30%

Status:
Not yet recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The study aims to assess the impact of models of HCV care on HCV testing, treatment uptake and cure within Cairns. Point of care testing for HCV , with test and treat strategies will be offered within a primary care service.
Phase:
Phase 4
Details
Lead Sponsor:
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Collaborators:
Cairns Hinterland Health Hospital and Health Services
The University of Queensland
Treatments:
Sofosbuvir-velpatasvir drug combination